Business
Nanalysis Reports First Quarter 2023 Results
Nanalysis Reports First Quarter 2023 Results Canada NewsWire CALGARY, AB ...
About this update from Nanalysis Scientific Corp
[{"type":"text","content":"\n \n \n \n Nanalysis Reports First Quarter 2023 Results\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen2{\nPADDING-RIGHT:0.17em; PADDING-LEFT:0.17em; VERTICAL-ALIGN: TOP; BORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; BORDER-BOTTOM:black 0pt; BORDER-LEFT:black 0pt\n}\n.prnml4{\nMARGIN-TOP:0em; MARGIN-RIGHT:0em; MARGIN-BOTTOM:0em; MARGIN-LEFT:0.33em !IMPORTANT\n}\n.prnbcc{\nBORDER-COLLAPSE: COLLAPSE\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n CALGARY, AB\n \n \n ,\n \n \n May 25, 2023\n \n \n /CNW/ -\n \n Nanalysis Scientific Corp.\n \n (\"the Company\",\n \n TSXV: NSCI\n \n ,\n \n OTCQX: NSCIF\n \n ,\n \n FRA: 1N1\n \n ), a leader in portable NMR machines and MRI technology for industrial and research applications, releases its first quarter results ending March 31, 2023. Chief Executive Officer, Sean Krakiwsky and Chief Financial Officer, Randall McRae will host a conference call at 5 P.M. Eastern Time today to discuss the results. The second call for European investors at\n \n 8:30am ET\n \n , tomorrow,\n \n Friday, May 26\n \n has been cancelled since Mr. Krakiwsky will be conducting meetings in person.\n \n \n \n \n \n \n \n \n \n \"Nanalysis reported consolidated revenue of\n \n $4,674K\n \n for the first quarter of 2023,\" said Sean Krakiwsky Founder and CEO of Nanalysis. \"We planned and expected K'Prime's CATSA airport security contract and Quad's revenue to be modest in the quarter as those business lines are in the early stage of roll out, but we underperformed on the rest of our business segment revenues, particularly in Benchtop NMR.  Management is not satisfied with this overall financial result and has taken corrective action as identified below.  That being said, I remain confident about the Company's prospects and long term vision.\"\n \n \n \n Financial and Operational Highlights\n \n \n \n \n 1\n \n \n \n \n \n Financial highlights for the three months ended\n \n March 31, 2023\n \n :\n \n \n \n For the three months ended March 31, 2022, the Company reported consolidated revenue...